Summary & Overview
HCPCS G9698: Documentation of Reason for Not Prescribing Long-Acting Inhaled Bronchodilator
HCPCS Level II code G9698 records clinician documentation of system-level reasons for not prescribing a long-acting inhaled bronchodilator (for example, cost or lack of insurance). Nationally, this code matters because it captures nonclinical barriers to guideline-recommended pharmacologic therapy for obstructive lung disease and can inform quality measurement, care coordination, and payor coverage policy design. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what the code represents, how it is used in outpatient and ambulatory care documentation, and why systematic capture of nonprescription reasons matters for population health and payer programs. The publication reviews benchmark concepts and policy implications, outlines typical clinical contexts where documentation is expected, and highlights areas where data is not available in the input. Data not available in the input: specific associated taxonomies, ICD-10 diagnoses, related billing codes, and service-line specifics. This summary is intended for national audiences engaged in clinical documentation improvement, revenue cycle management, and payer policy.
Billing Code Overview
HCPCS Level II code G9698 documents the system reason(s) for not prescribing a long-acting inhaled bronchodilator (for example, cost of treatment or lack of insurance). This code captures clinician documentation explaining why a recommended long-acting inhaled bronchodilator was not prescribed as part of a patient’s care plan.
-
Service type: Clinical documentation of treatment decision rationale
-
Typical site of service: Outpatient clinic or ambulatory care setting
Clinical & Coding Specifications
Clinical Context
A patient with chronic obstructive pulmonary disease (COPD) or asthma presents to an outpatient primary care clinic or pulmonary specialty clinic for medication management. The clinician assesses the patient and determines that a long-acting inhaled bronchodilator would normally be indicated based on symptoms, spirometry, or exacerbation history. During the encounter the patient declines the medication or the clinician documents that the medication will not be prescribed due to systemic barriers such as prohibitive cost, lack of prescription drug coverage, formulary restrictions, inability to obtain a prior authorization, or absence of local pharmacy supply. The clinician documents the specific system reason(s) for not prescribing a long-acting inhaled bronchodilator in the medical record to support care continuity, patient counseling, and billing for the service using G9698. Typical workflow includes patient history and medication review, assessment and plan documentation specifying the system barrier, discussion of alternative therapies or nonpharmacologic measures, and coded billing from the outpatient visit. Typical sites of service are outpatient clinic, community health center, federally qualified health center, or telehealth visit when the barrier is discussed and documented.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when documentation supports substantially greater work for counseling or coordination related to addressing system barriers. |